1. A PHASE 1B/2 STUDY OF ORAL NANATINOSTAT (N) AND VALGANCICLOVIR (VG) IN SUBJECTS WITH EPSTEIN‐BARR VIRUS (EBV)‐ASSOCIATED LYMPHOMAS. (12th June 2019) Authors: Porcu, P.; Haverkos, B.; Brem, E.; Vallurupalli, A.; Feldman, T.; Alpdogan, O.; Brammer, J.; Bryan, L.J.; Barta, S.; Schriefer, A.; Obrzut, S.; Shen, H.; Rochford, R.; Baiocchi, R.; Casper, C.; Gutheil, J.; Melink, T.; Kearns, C.; Burner, D.; McRae, R. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOSE FINDING STUDY TO ASSESS SAFETY, PK AND EFFICACY OF FIMEPINOSTAT (CUDC‐907) WITH VENETOCLAX OR RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA. (12th June 2019) Authors: Younes, A.; Batlevi, C.L.; Cohen, J.B.; Kelly, K.; Landsburg, D.J.; Patel, K.; Phillips, T.; Smith, S.; Westin, J.; Ma, A.W.; Grayson, D.; Barta, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EVITA: PHASE I/II STUDY OF EVEROLIMUS PLUS ITACITINIB IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA. (12th June 2019) Authors: Svoboda, J.; Barta, S.; Nasta, S.; Landsburg, D.; Gerson, J.; Ruella, M.; Waite, T.; King, C.; Emanuel, S.A.; Ballard, H.; Schuster, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412). (12th June 2019) Authors: Diefenbach, C.S.; Hong, F.; Ambinder, R.; Cohen, J.; Robertson, M.; David, K.; Advani, R.; Fenske, T.; Barta, S.; Palmisano, N.; Svoboda, J.; Morgan, D.; Karmali, R.; Kahl, B.; Ansell, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY. (12th June 2019) Authors: Bond, D.A.; Switchenko, J.; Maddocks, K.; Churnetski, M.; Goyal, S.; Shanmugasundaram, K.; Calzada, O.; Kolla, B.; Bachanova, V.; Gerson, J.; Barta, S.; Hill, B.; Salwaha, Y.; Martin, P.; Maldonado, E.; Gordon, M.; Danilov, A.; Grover, N.; Mathews, S.; Burkart, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗